|
|
|
|
| LEADER |
00000nam a22000005i 4500 |
| 001 |
b3248034 |
| 003 |
MWH |
| 005 |
20191025031424.0 |
| 007 |
cr nn 008mamaa |
| 008 |
121227s1989 au | s |||| 0|eng d |
| 020 |
|
|
|a 9783709189948
|
| 024 |
7 |
|
|a 10.1007/978-3-7091-8994-8
|2 doi
|
| 035 |
|
|
|a (DE-He213)978-3-7091-8994-8
|
| 050 |
|
4 |
|a E-Book
|
| 072 |
|
7 |
|a MJN
|2 bicssc
|
| 072 |
|
7 |
|a MED056000
|2 bisacsh
|
| 072 |
|
7 |
|a MKJ
|2 thema
|
| 245 |
1 |
0 |
|a Early Diagnosis and Preventive Therapy in Parkinson’s Disease
|h [electronic resource] /
|c edited by Horst Przuntek, Peter Riederer.
|
| 250 |
|
|
|a 1st ed. 1989.
|
| 264 |
|
1 |
|a Vienna :
|b Springer Vienna :
|b Imprint: Springer,
|c 1989.
|
| 300 |
|
|
|a XIV, 447 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Key Topics in Brain Research,
|x 0934-1420
|
| 490 |
1 |
|
|a Springer eBook Collection
|
| 505 |
0 |
|
|a The premorbid personality of patients with Parkinson’s disease -- Parkinson’s disease: development of dementia in aging -- Psychometric assessment of early signs of dementia in special consideration of Parkinson’s and Alzheimer’s disease — an update -- Sensory and musculo-skeletal dysfunction in Parkinson’s disease—premonitory and permanent -- Autonomic nervous system screening in patients with early Parkinson’s disease -- Clinical and biochemical characteristics of early depression in Parkinson’s disease -- Psychomotor investigations in depressed patients by comparison with Parkinson patients -- Quantitative analysis of voluntary and involuntary motor phenomena in Parkinson’s disease -- Motor performance test -- Measuring body movements in neurological disease, with special reference to Parkinson’s disease -- Long-term measurement of tremor: early diagnostic possibilities -- Tremor and electrically elicited long-latency reflexes in early stages of Parkinson’s disease -- Evoked potentials in Parkinson’s disease -- Brain mapping of EEG and evoked potentials during physiological aging and in Parkinson’s disease, dementia and depression -- Positron emission tomography in Parkinson’s disease glucose metabolism -- Parkinson’s disease studied using PET -- Pathobiochemistry of the extrapyramidal system: a “short note” review -- Dopaminergic neurotransmission and status of brain iron -- Dopaminergic modulation of neuropeptide gene expression in the rat striatum -- The diagnostic relevance of Lewy bodies and other inclusions in Parkinson’s disease -- Cytoskeletal pathology of the Lewy bodies -- Plasma concentrations of endogenous DOPA and 3-O-methyl-DOPA in rats administered benserazide and carbidopa alone or in combination with the reversible COMT inhibitor Ro41-0960 -- Catecholamines in urine, blood and cerebrospinal fluid -- 3H-spiperone binding to lymphocytes is increased in schizophrenic patients and decreased in parkinson patients -- Platelet MAO-B activity in humans and stumptail monkeys: in vivo effects of the reversible MAO-B inhibitor Ro19-6327 -- Aspartate, glutamate, and glutamine in platelets of patients with Parkinson’s disease -- Hypothalamic dysfunction and neuroendocrine research in Parkinson’s disease -- The MPTP model: an update -- Histochemistry of MAO subtypes in the brainstem of humans: a relation to the radical hypothesis of Parkinson’s disease? -- Importance of dopaminergic and GABAergic neurones of the nucleus accumbens and the caudate nucleus for motoricity -- Is D-1 receptor stimulation important for the anti-parkinson activity of dopamine agonists? -- Pharmacological and clinical-pharmacological aspects of D1- and D2-receptors -- Chemical modulation of membrane-bound receptors -- Transplantation of dopamine-synthesizing cells — new therapy for Parkinson’s disease? -- L-dopa in Parkinson’s disease -- Pharmacokinetic investigations of various levodopa formulations -- Iron therapy in Parkinson’s disease. Stimulation of endogenous presynaptic L-DOPA biosynthesis by the iron compound oxyferriscorbone -- Provisional experiences with the combination of L-dopa and L-deprenyl -- Clinical pharmacology of amantadine and derivatives -- Dopamine agonist treatment in early Parkinson’s disease -- Subcutaneous apomorphine in Parkinson’s disease -- Continuous dopaminergic stimulation with parenteral lisuride in complicated Parkinson’s disease -- Discussion.
|
| 590 |
|
|
|a Loaded electronically.
|
| 590 |
|
|
|a Electronic access restricted to members of the Holy Cross Community.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
|
0 |
|a Internal medicine.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Biochemistry.
|
| 690 |
|
|
|a Electronic resources (E-books)
|
| 700 |
1 |
|
|a Przuntek, Horst.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 700 |
1 |
|
|a Riederer, Peter.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 830 |
|
0 |
|a Key Topics in Brain Research,
|x 0934-1420
|
| 830 |
|
0 |
|a Springer eBook Collection.
|
| 856 |
4 |
0 |
|u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-3-7091-8994-8
|3 Click to view e-book
|t 0
|
| 907 |
|
|
|a .b32480349
|b 04-18-22
|c 02-26-20
|
| 998 |
|
|
|a he
|b 02-26-20
|c m
|d @
|e -
|f eng
|g au
|h 0
|i 1
|
| 912 |
|
|
|a ZDB-2-SME
|
| 912 |
|
|
|a ZDB-2-BAE
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
| 902 |
|
|
|a springer purchased ebooks
|
| 903 |
|
|
|a SEB-COLL
|
| 945 |
|
|
|f - -
|g 1
|h 0
|j - -
|k - -
|l he
|o -
|p $0.00
|q -
|r -
|s b
|t 38
|u 0
|v 0
|w 0
|x 0
|y .i21611993
|z 02-26-20
|
| 999 |
f |
f |
|i d7d3791b-b5c3-5fcb-bb94-5796ba6e77a0
|s 2961aa89-2295-5da6-ab47-3914b0d89494
|t 0
|
| 952 |
f |
f |
|p Online
|a College of the Holy Cross
|b Main Campus
|c E-Resources
|d Online
|t 0
|e E-Book
|h Library of Congress classification
|i Elec File
|